Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian Cancer
Real-world benefit seen with addition of bevacizumab to first-line chemotherapy for patients with high‐risk prognostic factors
FDA Approves At-Home Cervical Cancer Test for Women Ages 25 to 65
President Signs Executive Order to Lower Some Drug Costs
Order expected to affect specific medications covered under Medicare that are administered in a health care setting
Multicancer Early Detection Screening Improves Patient Outcomes
More favorable diagnostic yield seen with annual versus biennial screening
Computer-Aided Design and Manufacturing Assists Jaw Reconstruction
Findings show shorter operating time and lower risk for long-term complications requiring hardware removal versus conventional techniques
Trump Taps Wellness Influencer Casey Means for Surgeon General
Ultra-Hypofractionated Radiotherapy Noninferior for Prostate Cancer
UHF noninferior to conventionally fractionated radiotherapy for men with intermediate- to high-risk localized disease
Targeted Grant Terminations Have Affected 694 NIH Grants
Terminations resulted in $1.81 billion in terminated grant funding; 30.0 percent had not been expended at time of termination
American Association for Cancer Research, April 25-30
Racial Disparities Persist in Immediate Breast Reconstruction Rates
Finding seen despite increases in rates overall and passage of the Affordable Care Act
